• Created by Unknown User (clrichar@mit.edu), last modified by Unknown User (lylaatta@mit.edu) on Jun 18, 2015 19:48

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 13 Next »

Experiments


Transfection Optimization

Small Molecule Induction Characterization

Linker Optimization

Expression Level Optimization

To Lyn or not to Lyn 

Antibodies

 


BCR 2.0 Experiments Chart

 

 

 

 

 

To Be Planned: 

Lyn transfection:

Do we need to transfect any additional Lyn or can we rely on endogenous levels of Lyn? If we cannot rely on endogenous Lyn, what concentrations on Lyn are sufficient for functioning of BCR. 

Transfection protocols: 

Characterizing effectiveness of different transfection protocols. We want to test Lipofectamine transfection with adhered cells vs. cells in suspension and possibly with the new transfection reagent jetprime. 

Amounts of transfected plasmids: 

What are the minimum amounts of plasmid we need in a multiple plasmid transfection? hEF1a:rTta, TRE:gal4vp16, gal4UAS:X1FP, hEF1a:X2FP, hEF1a:X3FP. Possible concentrations: 10ng, 25ng, 50ng, 100ng, 250ng, 500ng, 1000ng. 

Expression level optimization: 

LacI controlled BCR expression and TRE controlled Syk-TEVp expression level optimization. 

+ve control: hEF1a:Gal4VP16 --> XFP.

 

 

  • No labels